drugset / Trial / NCT07305519
The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth:
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of the study is to assess the effect of a combination of Magnesium, Palmitoylethanolamide, high-molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in women at risk of preterm birth (PTB).
Timeline
- Start
- 2026-04-01
- Primary completion
- 2027-04-01
- Completion
- 2028-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyaluronic Acid | Other / unclassified | 200 mg | Oral |
| Subject | Magnesium Sulfate | Other / unclassified | 450 mg | Oral |
| Subject | Palmidrol | Small molecule | 200 mg | Oral |
| Subject | Pyridoxine | Unknown | 2.6 mg | Oral |
| Subject | Vitamin D | Other / unclassified | 50 ug | Oral |
| Background | Progesterone | Other / unclassified | 200 mg | Other |
Indications
No indication recorded.